NCT07161232 The Influence of the Timing of Postoperative Rehabilitation Intervention on the Clinical Efficacy of Unilateral Biportal Endoscopic Spine System in the Treatment of Lumbar Disc Herniation
| NCT ID | NCT07161232 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Li Xiang |
| Condition | Lumbar Disc Herniation |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2025-03-28 |
| Primary Completion | 2026-11-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2025-03-28 with a primary completion date of 2026-11-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study focuses on the impact of the timing of postoperative rehabilitation intervention on the clinical efficacy of unilateral biportal endoscopic spine surgery in the treatment of lumbar disc herniation. The main objective is to explore this impact and provide high-quality evidence-based medical evidence for making reasonable clinical decisions.
Eligibility Criteria
Inclusion Criteria: * Aged between 19 and 65 years. Diagnosed with lumbar disc herniation by imaging and scheduled for unilateral biportal endoscopic (UBE) surgery. Presenting with radicular pain in the lower extremity, with a history of less than 1 year. Able to understand Chinese and complete questionnaires independently. Physically capable of participating in exercise rehabilitation. Willing to participate and provide written informed consent. Exclusion Criteria: * Aged under 18 or over 65 years. Combined with other spinal pathologies (e.g., ankylosing spondylitis, rheumatoid arthritis, spinal tumor, spinal fracture, cauda equina syndrome). Diagnosis of neurological disorders (e.g., multiple sclerosis, Parkinson's disease). Presence of uncontrolled cardiovascular, respiratory, or peripheral vascular diseases. History of severe psychiatric disorders (e.g., schizophrenia). Previous history of spinal surgery. Pregnancy or lactation. Inability to understand or comply with the study procedures.
Frequently Asked Questions
Who can join the NCT07161232 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 65 Years, studying Lumbar Disc Herniation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07161232 currently recruiting?
Yes, NCT07161232 is actively recruiting participants. Visit ClinicalTrials.gov or contact Li Xiang to inquire about joining.
Where is the NCT07161232 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07161232 clinical trial?
NCT07161232 is sponsored by Li Xiang. The trial plans to enroll 72 participants.